Dergiler / Türk Onkoloji Dergisi / 2021 / Cilt: 36 - Sayı: 1

The Effects of COVID-19 Pandemic on the Follow-Up and Treatment Process of Gynecological Cancers and Breast Cancer

Sayfa
133–138
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Patients diagnosed with cancer during the COVID-19 pandemic should not be lost, followup and treatment should be continued without disruption, patients should be remembered to be in the high-risk group in this process and necessary hygiene measures should be taken in both follow-up and treatment concerning risks and COVID-19 pandemics

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:SUMMARY The present review was written to describe the effects of the COVID-19 pandemic on followup and treatment process of gynecological cancers and breast cancer in accordance with current literature, guidelines from national and international cancer associations.
📊
Temel Bulgular & Veri:Although opinions in all types of cancer differ among themselves, general beliefs are postponement of non-urgent surgical operations, re-evaluation of chemotherapy processes, postponing appointments for new nonurgent diagnoses, reducing the length of hospital stay of patients in emergency procedures, conducting consultations by telemedicine or telephone, treatment of patients with COVID-19 suspicions after 15 days, planning biopsies or surgeries according to the staging status of cancers and planning conferences as video conferences in cases that require a multidisciplinary approach.
💡
Sonuç & Katkı:Patients diagnosed with cancer during the COVID-19 pandemic should not be lost, followup and treatment should be continued without disruption, patients should be remembered to be in the high-risk group in this process and necessary hygiene measures should be taken in both follow-up and treatment concerning risks and COVID-19 pandemics
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

SUMMARY The present review was written to describe the effects of the COVID-19 pandemic on followup and treatment process of gynecological cancers and breast cancer in accordance with current literature, guidelines from national and international cancer associations. Recommendations were provided based on the consensus conference model. In the follow-up and treatment process of gynecological cancers and breast cancer, there are many factors, such as the clinical course of patient, the possibility of an emergency of the patient, the stage of the cancer and the current status of the chemotherapies. Although opinions in all types of cancer differ among themselves, general beliefs are postponement of non-urgent surgical operations, re-evaluation of chemotherapy processes, postponing appointments for new nonurgent diagnoses, reducing the length of hospital stay of patients in emergency procedures, conducting consultations by telemedicine or telephone, treatment of patients with COVID-19 suspicions after 15 days, planning biopsies or surgeries according to the staging status of cancers and planning conferences as video conferences in cases that require a multidisciplinary approach. Patients diagnosed with cancer during the COVID-19 pandemic should not be lost, followup and treatment should be continued without disruption, patients should be remembered to be in the high-risk group in this process and necessary hygiene measures should be taken in both follow-up and treatment concerning risks and COVID-19 pandemics

🔖

Bu Makaleye Atıf Yap

DOĞAN, R. A., GÜDÜCÜ, N. (2022). The Effects of COVID-19 Pandemic on the Follow-Up and Treatment Process of Gynecological Cancers and Breast Cancer. Türk Onkoloji Dergisi, Cilt: 36 - Sayı: 1, 133–138. https://ajindex.com/articles/639110

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Cafarotti S, Patella M. Lung Cancer Surgical Management During the Outbreak of Coronavirus Disease 2019. J Thorac Oncol 2020
  2. 15(6):e81 2. Calabrò L, Peters S, Soria JC, Di Giacomo AM, Barlesi F, Covre A, et al. Challenges in lung cancer therapy during the COVID-19 pandemic. Lancet Respir Med 2020
  3. 8(6):542–4. 3. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020
  4. 395(10223):507–13. 4. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020
  5. 20(4):425–34. 5. Ministry of Health. Türkiye Republic Ministry Of Health Corona Table [Internet]. Available at: https:// covid19.saglik.gov.tr. Accessed Apr 01, 2020. 6. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020
  6. 395(10223):497– 506. 7. World Health Organization. Novel coronavirus [COVID-19] situation [Internet]. Available at: https:// www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed Apr 16, 2020. 8. Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, et al. Fair Allocation of Scarce Medical Resources in the Time of Covid-19. N Engl J Med 2020
  7. 382(21):2049–55. 9. Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol 2020
  8. 21(5):629–30. 10.The Lancet Oncology. COVID-19: global consequences for oncology. Lancet Oncol 2020
  9. 21(4):467. 11.ESMO. COVID-19 and Canser Manage [Internet]. Available at: https://www.esmo.org/covid-19-andcancer/supporting-oncology-professionals. Accessed Apr 15, 2020. 12.Turkish Society of Medical Oncology. Cancer patients and their relatives [Internet]. Available at: https:// www.kanser.org/saglik/toplum/style/Covid19_hasta_ onerileri.pdf. Accessed Apr 1, 2020. 13.Sümbül AT, Yalçın Ş, Özet A, Ünal S, Dizdar Ö, Akbulut H, et al. Turkish medical oncology society covid-19 pandemic advisory board recommendations for cancer patients and medical oncologist. J Oncol Sci 2020
  10. 1(6):1–4. 14.Sidaway P. COVID-19 and cancer: what we know so far. Nat Rev Clin Oncol 2020
  11. 17(6):336. 15.Public Health Authority of The Republic of Turkey. Turkish Cancer Statistics 2015. Available at: https:// hsgm.saglik.gov.tr/depo/birimler/kanser-db/istatistik/ Trkiye_Kanser_statistikleri_2015.pdf. Accessed Nov 19, 2020. 16.AS